Ocean Biomedical Inc. (NASDAQ: OCEA) – An Incubator with Potential Treatments for Cancer, Malaria and Fibrosis – Initiating Coverage
Highlights This company, formed in 2019, and based out of Rhode Island, U.S., is a biopharma...
Read More
Biotech & Healthcare
Ocean Biomedical Inc. (NASDAQ: OCEA) – An Incubator with Potential Treatments for Cancer, Malaria and Fibrosis – Introductory Note
Highlights This company, formed in 2019, and based out of Rhode Island, U.S., is a biopharma...
Read More
Hemostemix Inc. (TSXV: HEM / OTC: HMTXF) – Awaiting Results of Phase II Trials of a Potential Therapy for Cardiovascular Diseases – Initiating Coverage
Highlights Based out of Alberta, this company is a clinical-stage (pre-revenue) biotechnology...
Read More
Voyageur Pharmaceuticals Ltd. (TSXV: VM) – Robust PEA / Launching First Suite of Products Next Month
Highlights A Preliminary Economic Assessment (PEA) on the Frances Creek barite project (B.C.)...
Read More
Sigyn Therapeutics Inc. (OTC PINK: SIGY) – A Potential Solution for The Primary Cause of Death During the COVID-19 Pandemic – Initiating Coverage
Highlights This company is a pre-revenue stage medical technology company focused on the treatment...
Read More
Building a Chain of Mental Health/Addiction Clinics & Pharmacies for the Burgeoning Psychedelic Sector – Initiating Coverage
Highlights Levitee Labs was founded in 2020, and went public in July 2021. It is a Vancouver-based...
Read More
Lexaria Bioscience Corp. (NASDAQ: LEXX) Drug Delivery Tech With Multiple Mainstream Applications – Resuming Coverage
Highlights Lexaria’s DehydraTECHTM is a patented and proprietary drug delivery technology for...
Read More
Voyageur Pharmaceuticals Ltd. (TSXV: VM) – Initiating Coverage: Junior Resource Company Building a Fully Integrated Pharmaceutical Company
Key Highlights Voyageur Pharmaceuticals Ltd. (“company”, “VM”), holder of three barium projects in...
Read More